Immunotherapy
Immunotherapy is revolutionizing cancer treatment by using the body’s own immune system to fight cancer cells. Learn about the latest advancements, clinical trials, and how this cutting-edge approach is improving patient outcomes.
Eating this staple food could reduce bowel cancer risk, study finds
Consuming yoghurt regularly may reduce bowel cancer risk by altering the body’s gut bacteria, a new study has found.
Have This Gut Healthy Snack Twice A Week, It Can Protect You From Aggressive Colorectal Cancer
A popular snack known for its probiotic and gut health benefits is gaining attention after researchers discovered it could be linked to a reduced risk of colorectal cancer. The new finding offers hope as cases rise, particularly among young adults.
Popular Breakfast Food Could Protect Against Colon Cancer, New Study Finds
y now, you’ve probably read about the dramatic rise in colon cancer among young people. According to 2023 data from the American Cancer Society, diagnoses in people under 55 years accounted for 11 percent of colon cancer in 1995, but that number doubled to 20 percent in 2019. Across age groups, “colorectal cancer is the third most commonly diagnosed cancer and the third leading cause of cancer death in both men and women in the U.S.” the Society states.
How scientists redesigned an effective cancer therapy to make it safer
University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its severe side effects, like blood clots and liver damage. If approved, the new drug may be tolerated by a broader range of leukemia patients and even be used to treat other cancers.
Gene discovery revolutionizes the detection and treatment of prostate cancer
A recent gene discovery has the potential to revolutionize how prostate cancer is detected and treated, offering new hope for patients.
Enhertu Approved for HR+, HER2-Low/Ultralow Metastatic Breast Cancer
Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial.
Scientists uncover how cancer cells hijack T-cells, making it harder for the body to fight back
Research led by the Chiba Cancer Center Research Institute in Japan has discovered a surprising way cancer evades the immune system. It essentially hacks the immune cells, transferring its own faulty mitochondrial DNA (mtDNA) into the T-cells meant to attack it.
First study on ‘very young’ colon cancer patients reveals risk factors
A first-of-its-kind global study from researchers at Renmin Hospital of Wuhan University in China has revealed the main risk factors for early-onset colon cancer around the world.
Bristol Myers’ colorectal cancer drug significantly reduces relapse risk
Clinical trials indicate that Bristol Myers’ new drug effectively lowers the risk of cancer relapse in colorectal patients.
Cancer breakthrough: New jab could slash risk of cervical cancer
More than half of those given a new vaccine in a clinical trial saw their pre-cancerous cells destroyed
Chinese team says vaccine shows promise in treating breast cancer in mice
Nanovaccine achieved tumour inhibition rate of 89.3 per cent when tested on mice with aggressive form of the disease, study finds.
Aspirin does not help prevent colon cancer recurrence
Aspirin does not help prevent colon cancer recurrence
